Phototropic Leaflet Reorientation in Alfalfa Germplasm Selected for Leaf Color and Size

Solar tracking has been described in several agronomic and wild species, yet variation within a given species has not been reported. To address that issue, photoperiod leaflet reorientation in response to vectorial light was measured in three alfalfa ( Medicago sativa L.) germplasm pools selected from the cultivar Ladak 65. Dark-leaf germplasm responded to all photosynthetic photon flux densities (PPFD) (100 to 700 μmol/m²/s) with no detectable lag period. Following a 24-h dark treatment only high PPFD (600 to 700μmol/m²/s) elicited reorientation. Pale-leaf germplasm responded to intermediate (300 to 400 μmol/m²/s) and high PPFD in a similar manner; however, the low (100-125μmol/m²/s) PPFD treatment had little effect on reorientation. The 24-h dark treatment decreased reorientation at all PPFD. Small-leaf germplasm responded equally to all PPFD and was not affected by the 24-h dark treatment. The results suggest that available energy levels may influence the reorientation response. Carbonyl cyanide m -chlorophenylhydrazone, an inhibitor of photophosphorylation, and 3-(3,4-dichlorophenyl)-1,1-dimethylurea, an inhibitor of non-cyclic photosynthetic electron transport, reduced reorientation only in the pale-leaf type. These results suggest that stored energy reserves were adequate to maintain leaflet reorientation in the absence of photosynthesis in all but the pale-leaf germplasm. In that germplasm photosynthetically generated energy may be required to support reorientation.     

Gross Morphometry of the Bovine Placentome during Gestation

Forty-seven pregnant uteri were collected from an abattoir at eight chronological stages of gestation. Assessments were made of placentome number, weight, length shape and ratio of foetal to maternal tissue by weight. The study showed that there was a great variation in number, size, weight and shape of placentomes. There was no significant change in the total number of placentomes during gestation. Both mean weight and length increased significantly during gestation, but there was a significant change in the relationship between the two as gestation progressed. There was no correlation between the number of placentomes and the mean weight or length of the placentomes. The development of the placenta in the non-pregnant horn was significantly different from that of the pregnant horn, with fewer, smaller, lighter placentomes. However, there was no evidence that placentome development in the non-pregnant horn was affected by placentome development in the pregnant horn. The proportion of the placentome that was maternal tissue increased during gestation, but there was no significant effect of placentome number, or individual placentome weight or length on this proportion. Two placentome shapes were identified, but no effect on foeto-maternal proportion or relationship between shape and total placentome number or weight was identified.     

The neurologic examination of the horse for purchase.

The veterinarian needs to be able to incorporate an accurate neurologic examination as a portion of the pre-purchase evaluation. Subtle neurologic deficits may be hidden by musculoskeletal disease or missed as a result of lack of knowledge or understanding of these disorders. It is important to known which musculoskeletal disorders are commonly associated with neurologic disease to better assist the buyer with the decision about whether to purchase the animal.     

Reduction of the red blood cell mass of horses: toxic effect of heparin anticoagulant therapy

This study was designed to test the efficacy of heparin anticoagulant therapy in the horse and its effect on the formed elements of blood. Nine clinically normal, nontraumatized adult horses were subjected to 4 different heparin maintenance regimens (dosages of 320, 240, 160, and 40 U/kg of body weight). Porcine intestinal mucosa heparin (20,000 U/ml) was injected subcutaneously every 12 hours for 96 hours (total 9 times). A loading dose of one-third the maintenance dose was given IV just before the first heparin injection. Three control horses were given an equivalent volume of 0.9% saline solution. The 2 large doses of heparin (320, 240 U/kg) resulted in an extension of the therapeutic range for heparin anticoagulant therapy (1.5 to 2.5 X data base-line prolongation of the activated partial thromboplastin time [APTT]). The 160-U/kg dose maintained the APTT in the therapeutic range, and the 40-U/kg dose had no effect on the APTT. Heparin was shown to exert a profound influence on the RBC mass of the horse. Three of the heparin regimens (320, 240, and 160 U/kg) resulted in a significant decrease in RBC numbers, PCV, and total hemoglobin content. Platelet count also was reduced in the horses when given the 320 and 240 U/kg doses. The observed increase in the mean corpuscular volume was associated with decreasing RBC numbers. Plasma proteins, serum bilirubin, free hemoglobin (plasma), haptoglobin (plasma), and urine and fecal hemoglobin values remained unchanged in all groups. Heparin anticoagulation therapy with the smallest dose (40 U/kg) had no detectable effects on the measured values, nor did the saline solution.     

Cross-reactions of bovine herpesvirus 1 antigens with those of other cattle herpesviruses

Bovine embryonic kidney cells were infected with bovine herpesviruses (BHV1, 2, or 3), suid herpesvirus 1 (SHV1), or were sham-inoculated. When cytopathic effect was apparent, the cells were solubilized using Triton X-100 detergent. Resulting antigen preparations were tested by 2-dimensional immunoelectrophoresis using bovine fetal serum and antisera directed against BHV1, BHV2, BHV3, SHV1 or a restricted spectrum of BHV1 antigens. Interaction of BHV1 antiserum with BHV1 antigen preparations resulted in 11 precipitation arcs. The same antiserum produced 3 arcs with BHV2, none with BHV3, and 5 with SHV1. The interaction of BHV1 antigen preparations with BHV2, BHV3, or SHV1 antisera failed to produce demonstrable arcs. However, when heterologous antigen or antibody preparations were added to BHV1 homologous 2-dimensional immunoelectrophoresis tests, all 11 BVH1 arcs were modified by BHV1, 2 by BHV2, 4 by BHV3 and 4 by SHV1 preparations. Two antigens were common to the 4 herpesviruses. Antigen preparations were tested for their ability to inhibit virus neutralization by BHV1 antiserum; only the BHV1 preparation was active. Sera were tested for BHV1 neutralizing activity; only BHV1 antiserum and a serum specific for a restricted spectrum of BHV1 antigens were active. A glycoprotein antigen associated with BHV1 neutralization was identified which may be important in the protection of animals against disease.